EU agrees potential 1.8 billion-dose purchase of Pfizer vaccine
Published
The European Union has cemented its support for Pfizer/BioNTech and its novel Covid-19 vaccine technology by agreeing to a massive contract extension for a potential 1.8 billion doses until 2023.
Full Article